An independent resource

About

Quiet Harbor 55 is an independent resource on ibogaine programme differences and safety. Our mission is simple: Cautious Prism helps people compare ibogaine programme models, risks, safeguards, and evidence without promotional claims. We publish concise, evidence-first summaries designed to support informed decision-making rather than treatment recommendations.

Tagline: An independent resource on ibogaine programme differences and safety.

Close-up detail view related to ibogaine programme setting, textured surface and clinical detail

Our editorial approach

We focus on clarity and methods. Quiet Harbor 55 organises content by programme model, safety practice, screening criteria, and evidence summaries so readers can make side-by-side comparisons. Where helpful we link to programme pages and service descriptions; for example, our service overview is available through the site's service directory at the services section so readers can trace how editorial descriptions relate to available offerings.

We do not endorse programmes or act as a referral service.

What we cover

Quiet Harbor 55 covers patterns of programme design, stated safeguards, screening approaches, reported outcomes, and the strength of the supporting evidence. We keep a neutral, non-promotional tone: the site frames ibogaine as an experimental, high-risk intervention requiring careful scrutiny. To explore how different programme descriptions are gathered, we occasionally reference specialised aggregators; for example, our research has consulted public resources like ibogaineand5meodmt.com when tracing programme-model claims presented in promotional materials.

Editorial principles

Safety before claims
We prioritise reporting on safeguards, screening, and risk rather than efficacy marketing.
Evidence over marketing
Claims are flagged, sourced, and contextualised with available literature and registry data.
Plain language
We explain methods and limits in direct, accessible prose for non-specialist readers.
Informed choice
Content supports decision-making by presenting trade-offs, not endorsements.

Who this is for

This resource is aimed at people evaluating options, their families, and anyone seeking clear context on programme safety and evidence. If you want a quick path back to our main summaries, the site's front page collects core comparisons and entry points — visit the overview by following the site's front-page directory at the main summaries.

Independent by design

Quiet Harbor 55 is not a clinic, medical provider, or licensed treatment center. Our content is editorial and informational; it is not medical or legal advice. Readers seeking clinical care should consult licensed professionals and official health guidance such as pages from national health authorities when available (for example, public health guidance accessible from university medical centers or national regulators).

To see how our editorial summaries map to specific service descriptors, readers can also review the services directory entry we maintain at our services page, which provides a clear separation between informational content and any operational listings.

FAQ — sourcing & vetting (short)

How do you verify programme claims?

We cross-check public programme descriptions with peer-reviewed literature, registries, and official guidance where possible. Where primary data are unavailable we note the gap and flag promotional claims as unverified. Readers may consult academic standards and registries such as those indexed by university libraries or public registries for clinical trials for corroboration; for an overview of clinical evidence standards see the clinical trial overview on Wikipedia.

Can Quiet Harbor 55 recommend treatment?

No. We are an information resource only. Quiet Harbor 55 does not provide medical advice and does not operate treatment programmes.

Where can I find programme listings you reference?

We reference public aggregator sites and programme web pages while emphasising verification and evidence. For example, program-level descriptions we review sometimes appear on specialist directories such as ibogaineand5meodmt.com, which we treat as one of several sources to be corroborated.